J&J To Face Bulk Of Buyers' Claims In Remicade Antitrust Suit
A Pennsylvania federal judge largely refused Friday to toss antitrust claims from buyers of Johnson & Johnson immunosuppressant Remicade, concluding that only sham litigation allegations and some state law consumer protection...To view the full article, register now.
Already a subscriber? Click here to view full article